MedTrace Logo

Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals

NCT00168259 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2012-01-20

No results posted yet for this study

Summary

The study is designed to evaluate interferon responses to CMV in HIV positive individuals and a component will look at interferon responses to CMV in HIV positive individuals over time after commencement of antiretroviral therapy. We will also look at the correlation between CD4 T cell numbers and HLA type with the interferon response.

Conditions

  • HIV Infection
  • CMV Infection

Sponsors & Collaborators

  • Cellestis

    collaborator INDUSTRY

  • The Alfred

    lead OTHER

Principal Investigators

  • Sharon Lewin, Professor · The Alfred

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Completion
2009-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168259 on ClinicalTrials.gov